Evidence map›Paper›PMID 34887579›Full record

ArticleNature protocols2022

Publisher Correction: A practical guide to large-scale docking.

Brian J Bender, Stefan Gahbauer, Andreas Luttens, Jiankun Lyu, Chase M Webb, Reed M Stein, Elissa A Fink, Trent E Balius, Jens Carlsson, John J Irwin and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Brian J Bender *Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Stefan Gahbauer *Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-3115-9757
Andreas LuttensScience for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-2915-7901
Jiankun LyuDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Chase M WebbDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Reed M SteinDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Elissa A FinkDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Trent E BaliusNCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-6811-4667
Jens CarlssonScience for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
John J IrwinDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA.
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA. bshoichet@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34887579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.